{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "GRND",
  "name": "Grindr Inc.",
  "url": "https://orbyd.app/dossiers/GRND/",
  "json_url": "https://orbyd.app/dossiers/GRND.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Product-led monetization pivot intact, but momentum has stalled: shares faded from $15.69 (7/10) to $14.85 (7/24) after Morgan Stanley's 2026-07-01 Overweight ($18 PT), heading into a binary Q2 print on 2026-08-06. EDGE ultra-premium tier is now a late-2026/2027 launch, so the re-rating hinges on the print clearing an already-raised FY guide (≥$535M revenue).",
  "invalidation_trigger": "A weekly close below $13 forfeits the rising 50-/200-day SMA cluster and the June recovery base; secondarily, an August 6 Q2 print with paying-user or ARPPU deceleration, a guidance cut, or EDGE priced well below the promised $100–500/month band.",
  "catalyst_date": "2026-08-06",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "consumer-discretionary-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Q2 2026 earnings CONFIRMED 2026-08-06 after close (call 2:00pm PT / 5:00pm ET) — binary print; enters the 3-trading-day blocker window ~2026-08-03, stand aside into it unless already based.",
    "EDGE ultra-premium tier ($100-500/mo) reframed by Morgan Stanley (2026-07-01, analyst Nathan Feather) as a late-2026/early-2027 launch, NOT a near-term print driver; a firm EDGE price disclosure is standalone narrative fuel.",
    "Woodwork telehealth (ED/GLP-1/peptides) projected ~$28M revenue by 2028; ~30% of users already use ED meds. MS models EDGE+Woodwork as ~60% of revenue growth through 2028 — longer-dated optionality.",
    "Short float ~27% (finviz 2026-07-10): squeeze fuel on a beat, sharp two-way volatility; size for it.",
    "Insider supply: CLO Zachary Katz sold 10,172 sh @ $15.95 on 2026-07-16 (routine 10b5-1 plan set 2026-03-18, still holds 703,151); management repurchased >$100M Dec-2025 through Q1-2026. Monitor San Vicente Form 4s on rallies toward $18-20.",
    "Momentum MATURING/fading since the 7/1 upgrade ($15.69 7/10 -> $14.85 7/24); for this theme the disciplined entry is a pullback that holds the 50-/200-day cluster and turns, not a chase into strength or into the print.",
    "Q1 2026 (2026-05-07): rev $130M +38% YoY vs $121.7M cons; adj EBITDA $58M (45% margin); APU +19% YoY, ARPPU +12% to $25.63; FY guide >=$535M rev / $227M adj EBITDA.",
    "Consensus PT ~$18.80, 5 buys / 0 sells (mid-July 2026); 52-week range $9.73-~$20; mkt cap ~$2.64B."
  ],
  "body_markdown": "## Current Thesis\nGrindr's re-rating story is the product-led monetization pivot — average paying users and price-per-user rising together, layered with two new revenue engines (the EDGE ultra-premium tier and the Woodwork telehealth brand). The thesis is intact but the momentum leg has cooled. Shares peaked near $20 in spring 2026, pulled back, bounced on Morgan Stanley's 2026-07-01 Overweight upgrade to $15.69 (2026-07-10), then faded to $14.85 (2026-07-24) — drifting back toward the rising moving-average cluster rather than extending. Everything now funnels into a single binary: the Q2 2026 print after the close on 2026-08-06, which must clear a guidance bar management already raised on 2026-05-07. The clean version of this trade is a pullback that holds the 50-/200-day cluster and turns, not a chase into the print.\n\n## Bull Case\n- **Beat-and-raise with margin proof (2026-05-07):** Q1 2026 revenue $130M, +38% YoY vs $121.7M consensus; adjusted EBITDA $58M at a 45% margin; net income $27M. App revenue $107M, advertising $23M. Full-year guide lifted to at least $535M revenue / $227M adjusted EBITDA. This is a GAAP-profitable subscription cash engine.\n- **Both pricing levers firing (Q1 2026):** Average Paying Users +19% YoY and ARPPU +12% to $25.63 — raising price without bleeding users, the hard part of any subscription network.\n- **Second and third revenue engines (Morgan Stanley, 2026-07-01, analyst Nathan Feather):** EDGE ultra-premium tier at $100–500/month (an Australia test near $80/month showed strong demand); Woodwork telehealth (ED treatment, GLP-1, peptides) projected at ~$28M revenue by 2028, with ~30% of users already on ED medication. MS models EDGE plus Woodwork as roughly 60% of revenue growth through 2028.\n- **Valuation vs growth (MS, 2026-07-01):** ~23% revenue growth modeled for 2026 and ~17% for 2027 on ~11x 2027 EBITDA; Overweight, $18 target. Street consensus target ~$18.80 with 5 buys and 0 sells as of mid-July 2026.\n- **Buyback under the price:** management repurchased over $100M of stock across December 2025 and Q1 2026, and short interest at ~27% (finviz, 2026-07-10) is covering fuel into any upside surprise.\n\n## Bear Case\n- **The upgrade bounce already reversed:** shares ran to a spring high near $20 ($19.58–$20.10 trailing 52-week high), gave back the move, bounced to $15.69 on the 2026-07-01 note, then slid to $14.85 by 2026-07-24. Price is fading into the catalyst, so the tape is repairing rather than accelerating.\n- **Elevated bar into 2026-08-06:** the full-year guide was already raised on 2026-05-07, so the Q2 print has to clear a lifted setup; any deceleration in paying users or ARPPU gets punished from a mid-range price.\n- **The big catalyst is an out-year story:** MS frames EDGE as a late-2026/early-2027 launch and Woodwork's $28M as a 2028 number — the premium-tier revenue is not a near-term print driver, so the re-rating leans on out-year execution the market has to underwrite on faith.\n- **EDGE pricing is unproven at scale:** the $100–500/month band rests on one small Australia test near $80/month; broad willingness-to-pay in that range is a bet, not a datapoint.\n- minor on its own, but the controlled register (San Vicente Acquisition) remains a rally cap, and app-store dependency plus content-moderation and privacy scrutiny are permanent tail risks.\n\n## Setup & Price Structure\nShares closed $14.85 on 2026-07-24, down from $15.69 on 2026-07-10, drifting toward a rising 50-day SMA near $13.5–14 and a 200-day SMA near $13. The buffer above the 50-day has compressed from roughly 17% in early July to high single digits, and the RSI that sat near 68 on 2026-07-10 has cooled back toward neutral. The intermediate uptrend is still intact with both averages rising beneath price, but the impulse from the July upgrade is spent — this is a maturing move settling into a range, mid-way inside a $9.73–$20 annual band. The constructive path is a base build near the moving-average cluster that holds through the 2026-08-06 print; the destructive path is a break of $13 that forfeits the June recovery structure. For a maturing theme like this one, the disciplined entry is a pullback that holds support and turns higher on volume, and fresh exposure ahead of a binary earnings date carries the full gap risk.\n\n## Catalyst Calendar (next 30 days)\n\n- **EDGE ultra-premium tier (undated, MS: late-2026/early-2027):** a firm pricing and launch-timing disclosure would be standalone narrative fuel independent of earnings, but nothing is scheduled inside the next 30 days.\n- **Woodwork telehealth (undated):** any rollout metric or partnership update is an unscheduled add-on to the story.\n- **Form 4 monitoring:** any San Vicente secondary or clustered insider sales on a rally toward the $18–20 zone.\n\n## Elapsed catalysts\n\n- **2026-08-06 (confirmed):** Q2 2026 results after the close; conference call 2:00 p.m. PT / 5:00 p.m. ET. This is the dominant near-term event and the entire setup pivots on it. It enters the 3-trading-day binary-risk window around 2026-08-03 — stand aside into the print unless already positioned on a clean base. *(passed 3d ago)*\n- **Analyst clustering:** watch for follow-on ratings behind Morgan Stanley (2026-07-01, OW $18); consensus target ~$18.80 as of mid-July 2026. *(passed 39d ago)*\n\n## What Would Change Our Mind\n- **Structural break:** a weekly close below $13 forfeits the rising 50-/200-day SMA cluster and the June recovery base — the re-rating structure is gone and the name reverts to a range-bound value question; stand aside.\n- **Fundamental break:** a 2026-08-06 print showing paying-user or ARPPU deceleration, a full-year guidance cut, or adjusted-EBITDA margin slipping meaningfully below the ~45% Q1 line — the \"both levers firing\" thesis fails and the multiple compresses.\n- **Catalyst break:** EDGE priced or received well below the promised $100–500/month band, or the launch slipping deeper into 2027 with no interim proof point — the second revenue engine loses credibility.\n- **Confirmation that would raise conviction:** a clean beat-and-raise on 2026-08-06 that holds paying-user growth in the high teens and positive ARPPU, plus a firm EDGE price at or above the band, with price reclaiming $16–17 on expanding volume and short covering — that flips the read from maturing to accelerating and becomes a setup to size.\n\n## Correlation Notes\n- **Theme:** consumer-discretionary-rotation, read as MATURING (2026-07-12). Trades with risk-on discretionary appetite; a macro-tightening turn pressures higher-multiple subscription names first.\n- **Dating/social peers:** MTCH (Match Group) and BMBL (Bumble). GRND's differentiator is demonstrated pricing power; a weak engagement or subscription-revenue print from MTCH or BMBL would get read across to GRND's \"raise price without losing users\" narrative regardless of GRND's own trajectory.\n- **Telehealth read-through:** Woodwork ties a small correlation to HIMS (Hims & Hers) on GLP-1 and ED demand trends.\n- **Idiosyncratic driver:** ~27% short interest means single-stock, news-driven two-way volatility that decouples from index beta; the 2026-08-06 print dominates correlation over the next month.\n- **Cap/beta:** ~$2.64B market cap places it in the small/mid-cap growth cohort, sensitive to rate and liquidity swings, though its GAAP profitability cushions the multiple relative to cash-burning peers.",
  "first_seen": "2026-07-08",
  "last_analyzed": "2026-07-31T06:12:29+00:00",
  "last_synthesized": "2026-07-26",
  "last_update_source": "theme_discovery",
  "license": "Content © orbyd. Cite the canonical URL."
}